MoneyWorks4Me

Gufic Biosciences informs about proceedings of AGM

03 Sep 2022 Evaluate

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gufic Biosciences has informed that it enclosed the proceedings of the 38th Annual General Meeting of the Equity Shareholders of the Company held on Friday, September 2, 2022, through Video Conferencing/ Other Audio-Visual Means.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..